CUHK_CCT00040
2005-09-08
Prospective
Not applicable
Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong
Nil
Nil
Miss Joyce Kung
3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon
27623134
joycekung@cuhk.edu.hk
Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong
Dr. Timothy Y.Y. Lai
3/F, Hong Kong Eye Hospital, 147K Argyle Street, Kowloon.
27623134
eyeclinic@cuhk.edu.hk
Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong
A randomized controlled trial on the safety and efficacy of a modified regimen of photodynamic therapy with verteporfin on acute central serous chorioretinopathy
A randomized controlled trial on the safety and efficacy of a modified regimen of photodynamic therapy with verteporfin on acute central serous chorioretinopathy
Nil
Hong Kong
Yes
2005-01-04
Eye Diseases
Procedure
Photodynamic therapy
12 months
Observation
Inclusion criteria: Aged 18 years or older
VA with Snellen equivalent of >/= 20/200
Greatest linear dimension of the entire lesion with ICG-A guidance must not exceed 5400 µm
Exclusion criteria: On exogenous corticosteroid Systemic diseases such as Cushing's disease or renal diseases of glomerulonephritis Pregnancy
Visual acuity worse than 20/200 in the affected eye
Myopia </= -6.00 diopters,
Presence of any choroidal neovascularization or other maculopathy
Tear (rip) of the retinal pigment epithelium
A history of laser photocoagulation Ocular surgery in the recent 3 months Any contraindication for the verteporfin infusion or fluorescein or ICG injection
18
None set
Both Male and Female
Interventional
Randomized
Placebo
Open label
Single group
2005-10-01
62
Complete
Complete absorption of subretinal fluid
electrophysiological results
2013-01-16
ChiCTR-TRC-05000639
2010-05-04
|
|
|
|
---|---|---|---|
No documents yet. |